
Merck agrees $3.9 billion takeover of SpringWorks
Merck KGaA has reached an agreement with SpringWorks on a $47-per-share takeover deal that values the US biotech at $3.9 billion. The acquisition – which was confirmed to be in the final stages of negotiation towards the end of last week – will " …